article thumbnail

Association between neutrophil to lymphocyte ratio and all-cause mortality in critical patients with coronary artery disease - a study based on the MIMIC-IV database

Frontiers in Cardiovascular Medicine

BackgroundNeutrophil-to-lymphocyte ratio (NLR) has been presented as a possible indicator associated with the outcomes of growing patients and an available predictor of inflammation. a comprehensive and large-scale single-center database. ResultsA total of 3,692 patients were included in this study.

article thumbnail

Revascularization Strategies in Stable Coronary Artery Disease: ISCHEMIA Trial Insights

Cardiology Update

In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. years, with 57.1% occurring within 30 days after CABG. years, with 21.1% occurring within 30 days after PCI.

article thumbnail

POST-PCI Surveillance Strategies for Multivessel or Left Main Coronary Artery Disease

Cardiology Update

The optimal surveillance strategy after percutaneous coronary intervention (PCI) for high-risk patients with multivessel or left main coronary artery disease (CAD) remains uncertain. The primary outcome was a composite of death from any cause, myocardial infarction, or hospitalization for unstable angina at 2 years.

article thumbnail

Advanced detection of coronary artery disease via deep learning analysis of plasma cytokine data

Frontiers in Cardiovascular Medicine

The 2017 World Health Organization Fact Sheet highlights that coronary artery disease is the leading cause of death globally, responsible for approximately 30% of all deaths. In this context, machine learning (ML) technology is crucial in identifying coronary artery disease, thereby saving lives.

article thumbnail

HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease

DAIC

The registry will collect multi-site, real-world information on how the Plaque Analysis product provides enhanced patient insights, empowering physicians and helping to inform their medical management decisions for patients with suspected coronary artery disease (CAD). Observed outcomes and biomarkers are secondary endpoints.

article thumbnail

How To Reverse Coronary Artery Disease With Lifestyle Measures

Dr. Paddy Barrett

Reversing or regressing coronary artery disease is possible. But can coronary artery disease be reversed with lifestyle measures, including changes to nutrition and exercise? In summary, the best outcome for plaque is to: Decrease in size Change from non calcified to calcified Develop a thick fibrous cap.

article thumbnail

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

DAIC

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform. Accessed May 2024. Leon, Shubin Qiao, Gregg W.